rdf:type |
|
lifeskim:mentions |
umls-concept:C0001645,
umls-concept:C0001688,
umls-concept:C0021149,
umls-concept:C0021888,
umls-concept:C0030705,
umls-concept:C0033522,
umls-concept:C0090306,
umls-concept:C0332173,
umls-concept:C0332298,
umls-concept:C0585361,
umls-concept:C0596545,
umls-concept:C0879626,
umls-concept:C1280500,
umls-concept:C1522577
|
pubmed:issue |
5
|
pubmed:dateCreated |
2002-6-19
|
pubmed:abstractText |
To assess the efficacy and side effects of 0.005% latanoprost once daily during 3 years of treatment in glaucomatous patients in whom intraocular pressure (IOP) was not adequately controlled by beta-blockers twice daily.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0721-832X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
240
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
379-86
|
pubmed:dateRevised |
2010-3-23
|
pubmed:meshHeading |
pubmed-meshheading:12073061-Adrenergic beta-Antagonists,
pubmed-meshheading:12073061-Adult,
pubmed-meshheading:12073061-Aged,
pubmed-meshheading:12073061-Antihypertensive Agents,
pubmed-meshheading:12073061-Female,
pubmed-meshheading:12073061-Follow-Up Studies,
pubmed-meshheading:12073061-Glaucoma, Open-Angle,
pubmed-meshheading:12073061-Humans,
pubmed-meshheading:12073061-Intraocular Pressure,
pubmed-meshheading:12073061-Male,
pubmed-meshheading:12073061-Middle Aged,
pubmed-meshheading:12073061-Ophthalmic Solutions,
pubmed-meshheading:12073061-Prospective Studies,
pubmed-meshheading:12073061-Prostaglandins F, Synthetic,
pubmed-meshheading:12073061-Safety,
pubmed-meshheading:12073061-Visual Fields
|
pubmed:year |
2002
|
pubmed:articleTitle |
Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients.
|
pubmed:affiliation |
Eye Clinic, University of Ferrara, Italy. sbd@dns.unife.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|